The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...

New WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for long-acting injectable cabotegravir for treatment, and Merck’s once-monthly ...

Even with the HIV prevention waters now dominated by Gilead Science’s Yeztugo (lenacapavir), Merck & Co. is not afraid to swim deeper in. | Even with the HIV prevention waters now dominated by Gilead ...

Ending USAID could lead to the deaths of 14 million people over the next five years, an analysis from a medical journal predicts.

U.S. funded treatments in the country have helped reduce deaths from HIV/AIDS to around 14,000 a year, from as high as ...

Breeze, a Louisville nonprofit that supports LGBTQ+ young adults, paused its free HIV testing services due to federal funding ...

PrEP vs. PEP: Thanks to changes in technology there are many medications designed for HIV, but how much do you know about them?

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread ...

To his surprise, they respond within an hour. After asking him questions about his sexual encounter and getting him to enter his personal details on a phone app, they connect him with a local ...

Haitians with HIV are defying stigma as they publicly denounce USAID cuts implemented by the Trump adminstration that have led to a dwindling of life-saving medication.

A class of HIV drugs known as nucleotide reverse transcriptase inhibitors (NRTIs) may help prevent Alzheimer’s disease, reducing risk by up to 13%, a new study suggests.

UVA scientists are calling for clinical trials to see if common HIV drugs could prevent up to 1 million new Alzheimer’s cases annually.